Eva Serrano‐Candelas

798 total citations
39 papers, 527 citations indexed

About

Eva Serrano‐Candelas is a scholar working on Molecular Biology, Immunology and Computational Theory and Mathematics. According to data from OpenAlex, Eva Serrano‐Candelas has authored 39 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Computational Theory and Mathematics. Recurrent topics in Eva Serrano‐Candelas's work include Computational Drug Discovery Methods (9 papers), Mast cells and histamine (8 papers) and Signaling Pathways in Disease (7 papers). Eva Serrano‐Candelas is often cited by papers focused on Computational Drug Discovery Methods (9 papers), Mast cells and histamine (8 papers) and Signaling Pathways in Disease (7 papers). Eva Serrano‐Candelas collaborates with scholars based in Spain, Italy and Germany. Eva Serrano‐Candelas's co-authors include Margarita Martı́n, Gabriel Gastaminza, Rosa Muñoz‐Cano, Sergio Martínez-Høyer, Mercè Pérez‐Riba, Marta Ferrer, M. J. Goikoetxea, Joan Bartra, Antonio Valero and Álvaro Aranguren‐Ibáñez and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Eva Serrano‐Candelas

34 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Serrano‐Candelas Spain 12 204 184 132 122 114 39 527
Susanna Choi South Korea 9 151 0.7× 132 0.7× 40 0.3× 48 0.4× 71 0.6× 16 370
Kazuhiro Nagahira Japan 14 174 0.9× 199 1.1× 33 0.3× 41 0.3× 23 0.2× 26 485
Robert H. Keith United States 12 150 0.7× 135 0.7× 20 0.2× 107 0.9× 41 0.4× 19 409
Yuka Sasakawa Japan 12 60 0.3× 282 1.5× 55 0.4× 42 0.3× 28 0.2× 20 472
Mariangela Correa Brazil 10 246 1.2× 336 1.8× 71 0.5× 47 0.4× 10 0.1× 18 649
Julia A. Guzova United States 9 221 1.1× 331 1.8× 15 0.1× 39 0.3× 39 0.3× 11 596
Jeffrey W. Pelker United States 7 251 1.2× 122 0.7× 20 0.2× 85 0.7× 19 0.2× 8 513
Giuseppe Dell’Elba Italy 11 160 0.8× 102 0.6× 94 0.7× 65 0.5× 18 0.2× 18 483
Donald C. Carpenter United States 11 197 1.0× 180 1.0× 36 0.3× 115 0.9× 17 0.1× 12 515
Helen Galczenski United States 9 113 0.6× 171 0.9× 57 0.4× 187 1.5× 11 0.1× 9 438

Countries citing papers authored by Eva Serrano‐Candelas

Since Specialization
Citations

This map shows the geographic impact of Eva Serrano‐Candelas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Serrano‐Candelas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Serrano‐Candelas more than expected).

Fields of papers citing papers by Eva Serrano‐Candelas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Serrano‐Candelas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Serrano‐Candelas. The network helps show where Eva Serrano‐Candelas may publish in the future.

Co-authorship network of co-authors of Eva Serrano‐Candelas

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Serrano‐Candelas. A scholar is included among the top collaborators of Eva Serrano‐Candelas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Serrano‐Candelas. Eva Serrano‐Candelas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serrano‐Candelas, Eva, Mario Guerrero, Carlos Lloréns, et al.. (2025). MITF regulates autophagy and extracellular vesicle cargo in gastrointestinal stromal tumors. Molecular Biomedicine. 6(1). 92–92.
2.
Guerrero, Mario, et al.. (2025). Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growth. PubMed. 33(2). 200983–200983. 1 indexed citations
3.
Palacio, J., Alessandra Roncaglioni, Domenico Gadaleta, et al.. (2025). DockTox: Targeting molecular initiating events in organ toxicity through molecular docking. Toxicology. 515. 154155–154155. 1 indexed citations
4.
Gadaleta, Domenico, et al.. (2024). Comprehensive benchmarking of computational tools for predicting toxicokinetic and physicochemical properties of chemicals. Journal of Cheminformatics. 16(1). 145–145. 2 indexed citations
5.
Moncho, Salvador, Eva Serrano‐Candelas, Jesus Vicente de Julián‐Ortiz, & Rafael Gozalbes. (2024). A review on the structural characterization of nanomaterials for nano-QSAR models. Beilstein Journal of Nanotechnology. 15. 854–866. 3 indexed citations
6.
Olivares, Marta, Alfonso Benítez‐Páez, Eva Serrano‐Candelas, et al.. (2024). Comparative Binding Study of Gliptins to Bacterial DPP4-like Enzymes for the Treatment of Type 2 Diabetes Mellitus (T2DM). International Journal of Molecular Sciences. 25(11). 5744–5744. 2 indexed citations
7.
Serrano‐Candelas, Eva, et al.. (2024). GenoITS: Implementation of an Integrated Testing Strategy workflow for genotoxicity using QSAR-based tools. 1. 100005–100005. 1 indexed citations
8.
Gadaleta, Domenico, et al.. (2024). Systematic evaluation of high-throughput PBK modelling strategies for the prediction of intravenous and oral pharmacokinetics in humans. Archives of Toxicology. 98(8). 2659–2676. 11 indexed citations
9.
Moreno‐Torres, Marta, Alfonso Quintás‐Cardama, Inger‐Lise Steffensen, et al.. (2024). Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support. Biomedicine & Pharmacotherapy. 174. 116530–116530. 1 indexed citations
10.
Ambure, Pravin, Eva Serrano‐Candelas, Mario Guerrero, et al.. (2023). G4-QuadScreen: A Computational Tool for Identifying Multi-Target-Directed Anticancer Leads against G-Quadruplex DNA. Cancers. 15(15). 3817–3817. 6 indexed citations
11.
Sancho, Mónica, Eva Serrano‐Candelas, Stephen J. Barigye, et al.. (2022). Identification of NLRP3PYD Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity. International Journal of Molecular Sciences. 23(3). 1651–1651. 13 indexed citations
12.
Serrano‐Candelas, Eva, et al.. (2022). The microphthalmia-associated transcription factor is involved in gastrointestinal stromal tumor growth. Cancer Gene Therapy. 30(2). 245–255. 7 indexed citations
13.
Ainsua‐Enrich, Erola, Eva Serrano‐Candelas, Rosa Muñoz‐Cano, et al.. (2021). MYO1F Regulates IgE and MRGPRX2-Dependent Mast Cell Exocytosis. The Journal of Immunology. 206(10). 2277–2289. 11 indexed citations
14.
Serrano‐Candelas, Eva, et al.. (2021). Author Correction: MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Scientific Reports. 11(1). 12449–12449.
15.
Landolina, Nadine, Eva Serrano‐Candelas, Dominik Schmiedel, et al.. (2020). Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells. Pharmacological Research. 158. 104682–104682. 21 indexed citations
16.
Serrano‐Candelas, Eva, et al.. (2018). MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Scientific Reports. 8(1). 11628–11628. 109 indexed citations
17.
Serrano‐Candelas, Eva, Gabriel Gastaminza, Joan Bartra, et al.. (2017). Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells. Scientific Reports. 7(1). 8985–8985. 8 indexed citations
18.
Serrano‐Candelas, Eva, Domènec Farré, Álvaro Aranguren‐Ibáñez, Sergio Martínez-Høyer, & Mercè Pérez‐Riba. (2014). The Vertebrate RCAN Gene Family: Novel Insights into Evolution, Structure and Regulation. PLoS ONE. 9(1). e85539–e85539. 18 indexed citations
19.
Martínez-Høyer, Sergio, Álvaro Aranguren‐Ibáñez, Javier Garcı́a-Garcı́a, et al.. (2013). Protein kinase CK2-dependent phosphorylation of the human Regulators of Calcineurin reveals a novel mechanism regulating the calcineurin–NFATc signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(10). 2311–2321. 14 indexed citations
20.
Aubareda, Anna, Mar Orzáez, Eva Serrano‐Candelas, et al.. (2009). Inhibiting the Calcineurin-NFAT (Nuclear Factor of Activated T Cells) Signaling Pathway with a Regulator of Calcineurin-derived Peptide without Affecting General Calcineurin Phosphatase Activity. Journal of Biological Chemistry. 284(14). 9394–9401. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanna Choi Breakdown of academic impact, for papers by Kazuhiro Nagahira Breakdown of academic impact, for papers by Robert H. Keith Breakdown of academic impact, for papers by Yuka Sasakawa Breakdown of academic impact, for papers by Mariangela Correa Breakdown of academic impact, for papers by Julia A. Guzova Breakdown of academic impact, for papers by Jeffrey W. Pelker Breakdown of academic impact, for papers by Giuseppe Dell’Elba Breakdown of academic impact, for papers by Donald C. Carpenter Breakdown of academic impact, for papers by Helen Galczenski
Rankless by CCL
2026